These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 7512210)
1. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo. Shephard SE; Lutz WK; Schlatter C Mutat Res; 1994 Apr; 306(2):119-28. PubMed ID: 7512210 [TBL] [Abstract][Full Text] [Related]
2. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L; Saranko CJ; Steen AM Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [TBL] [Abstract][Full Text] [Related]
3. Genotoxicity of agaritine in the lacI transgenic mouse mutation assay: evaluation of the health risk of mushroom consumption. Shephard SE; Gunz D; Schlatter C Food Chem Toxicol; 1995 Apr; 33(4):257-64. PubMed ID: 7737599 [TBL] [Abstract][Full Text] [Related]
4. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis. Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817 [TBL] [Abstract][Full Text] [Related]
5. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene. Recio L; Pluta LJ; Meyer KG Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685 [TBL] [Abstract][Full Text] [Related]
6. Use of transgenic mouse lacI/Z mutation assays in genetic toxicology. Ashby J; Tinwell H Mutagenesis; 1994 May; 9(3):179-81. PubMed ID: 7934956 [TBL] [Abstract][Full Text] [Related]
7. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene. Hayward JJ; Shane BS; Tindall KR; Cunningham ML Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147 [TBL] [Abstract][Full Text] [Related]
8. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice. Battershill JM; Fielder RJ Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Kirkland D; Aardema M; Müller L; Makoto H Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Kirkland D; Aardema M; Henderson L; Müller L Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392 [TBL] [Abstract][Full Text] [Related]
11. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice. Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740 [TBL] [Abstract][Full Text] [Related]
12. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Ashby J; Tennant RW Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047 [TBL] [Abstract][Full Text] [Related]
13. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Kirkland D; Reeve L; Gatehouse D; Vanparys P Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603 [TBL] [Abstract][Full Text] [Related]
14. Genotoxicity of o-aminoazotoluene (AAT) determined by the Ames test, the in vitro chromosomal aberration test, and the transgenic mouse gene mutation assay. Ohsawa K; Hirano N; Sugiura M; Nakagawa S; Kimura M Mutat Res; 2000 Nov; 471(1-2):113-26. PubMed ID: 11080667 [TBL] [Abstract][Full Text] [Related]
15. The results of assays in Drosophila as indicators of exposure to carcinogens. Vogel EW; Graf U; Frei HJ; Nivard MM IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of lacI mutation in germ cells and micronuclei in peripheral blood after treatment of male lacI transgenic mice with ethylnitrosourea, isopropylmethane sulfonate or methylmethane sulfonate. Gorelick NJ; Andrews JL; Gibson DP; Carr GJ; Aardema MJ Mutat Res; 1997 Feb; 388(2-3):187-95. PubMed ID: 9057880 [TBL] [Abstract][Full Text] [Related]
17. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Walker VE; Sisk SC; Upton PB; Wong BA; Recio L Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020 [TBL] [Abstract][Full Text] [Related]
18. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice. Winegar RA; Lutze LH; Hamer JD; O'Loughlin KG; Mirsalis JC Mutat Res; 1994 Jun; 307(2):479-87. PubMed ID: 7514721 [TBL] [Abstract][Full Text] [Related]
19. Short-term tests for defining mutagenic carcinogens. Waters MD; Stack HF; Jackson MA IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401 [TBL] [Abstract][Full Text] [Related]
20. Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice. Butterworth BE; Templin MV; Constan AA; Sprankle CS; Wong BA; Pluta LJ; Everitt JI; Recio L Environ Mol Mutagen; 1998; 31(3):248-56. PubMed ID: 9585263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]